Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2022-07-05 00:00:00 ET · period of report 2022-06-30 · accession 0001209191-22-040558 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-05 | 2022-06-30 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $11.58 | -20.0K | 778.9K | -2% | -$231.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-06-30 | S | D | 19,959 | $11.58 | 778,922 | D | — | — |